BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7248160)

  • 1. Elevated levels of prolactin in nulliparous women.
    Yu MC; Gerkins VR; Henderson BE; Brown JB; Pike MC
    Br J Cancer; 1981 Jun; 43(6):826-31. PubMed ID: 7248160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen and sex hormone-binding globulin levels in nulliparous and parous women.
    Bernstein L; Pike MC; Ross RK; Judd HL; Brown JB; Henderson BE
    J Natl Cancer Inst; 1985 Apr; 74(4):741-5. PubMed ID: 3857369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma hormones in parous, nulliparous and postmenopausal Japanese women.
    Hill P; Garbaczewski L; Kasumi K; Wynder EL
    Cancer Lett; 1986 Nov; 33(2):131-6. PubMed ID: 3098404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oestrogen profiles of parous and nulliparous women.
    Cole P; MacMahon B; Brown JB
    Lancet; 1976 Sep; 2(7986):596-9. PubMed ID: 61341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reproductive factors and family history of breast cancer in relation to plasma prolactin levels in premenopausal and postmenopausal women.
    Eliassen AH; Tworoger SS; Hankinson SE
    Int J Cancer; 2007 Apr; 120(7):1536-41. PubMed ID: 17211859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Permanent alterations induced in plasma prolactin and estrogen receptor concentration in benign and malignant tissue of women who started oral contraceptive use at an early age.
    Olsson H; Lindahl B; Ranstam J; Borg A; Fernö M; Norgren A
    Anticancer Res; 1987; 7(4B):853-6. PubMed ID: 3674773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated serum levels of estrogen and prolactin in daughters of patients with breast cancer.
    Henderson BR; Gerkins V; Rosario I; Casagrande J; Pike MC
    N Engl J Med; 1975 Oct; 293(16):790-5. PubMed ID: 1160970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the metoclopramide-induced prolactin release related to age at first full-term pregnancy or nulliparity.
    Parra A; Barrón J; Sinibaldi J; Coria I; Espinosa de los Monteros A
    Hum Reprod; 1997 Feb; 12(2):214-9. PubMed ID: 9070698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An abnormal luteal-phase evening peak of plasma prolactin in women with a family history of breast cancer.
    Kwa HG; Wang DY
    Int J Cancer; 1977 Jul; 20(1):12-4. PubMed ID: 561758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased hypothalamic dopaminergic tone only in early parous women with either malignant or benign breast tumors.
    Ortega-González C; Parra A; Barra R; Aranda C; Ramírez D; Di Castro P; Castro I; Zambrana M; Coria I
    Endocr Pract; 2002; 8(2):89-95. PubMed ID: 11942771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effect of a first pregnancy on the secretion of prolactin.
    Musey VC; Collins DC; Musey PI; Martino-Saltzman D; Preedy JR
    N Engl J Med; 1987 Jan; 316(5):229-34. PubMed ID: 3099198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined effect of childbearing, menstrual events, and body size on age-specific breast cancer risk.
    Kampert JB; Whittemore AS; Paffenbarger RS
    Am J Epidemiol; 1988 Nov; 128(5):962-79. PubMed ID: 3189296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen profiles of primiparous and nulliparous women in Athens, Greece.
    Trichopoulos D; Cole P; Brown JB; Goldman MB; MacMahon B
    J Natl Cancer Inst; 1980 Jul; 65(1):43-6. PubMed ID: 6930516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of parity on pregnancy hormonal profiles across ethnic groups with a diverse incidence of breast cancer.
    Arslan AA; Zeleniuch-Jacquotte A; Lukanova A; Afanasyeva Y; Katz J; Levitz M; Del Priore G; Toniolo P
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2123-30. PubMed ID: 17119037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An abnormal early evening peak of plasma prolactin in nulliparous and obese post-menopausal women.
    Kwa HG; Bulbrook RD; Cleton F; Verstraeten AA; Hayward JL; Wang DY
    Int J Cancer; 1978 Dec; 22(6):691-3. PubMed ID: 721324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships of age and reproductive characteristics with plasma estrogens and androgens in premenopausal women.
    Dorgan JF; Reichman ME; Judd JT; Brown C; Longcope C; Schatzkin A; Campbell WS; Franz C; Kahle L; Taylor PR
    Cancer Epidemiol Biomarkers Prev; 1995 Jun; 4(4):381-6. PubMed ID: 7655334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone levels in older women: a study of post-menopausal breast cancer patients and healthy population controls.
    Bernstein L; Ross RK; Pike MC; Brown JB; Henderson BE
    Br J Cancer; 1990 Feb; 61(2):298-302. PubMed ID: 2138030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary incontinence in nulliparous women and their parous sisters.
    Buchsbaum GM; Duecy EE; Kerr LA; Huang LS; Guzick DS
    Obstet Gynecol; 2005 Dec; 106(6):1253-8. PubMed ID: 16319249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor-1 genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating insulin-like growth factor-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families.
    Jernström H; Sandberg T; Bågeman E; Borg A; Olsson H
    Int J Gynecol Cancer; 2006; 16 Suppl 2():497. PubMed ID: 17010055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of parity on gestational age at delivery in multiple gestation pregnancies.
    James S; Gil KM; Myers NA; Stewart J
    J Perinatol; 2009 Jan; 29(1):13-9. PubMed ID: 18716629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.